TY - JOUR
T1 - Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome
AU - Colla, Simona
AU - Ong, Derrick Sek Tong
AU - Ogoti, Yamini
AU - Marchesini, Matteo
AU - Mistry, Nipun A.
AU - Clise-Dwyer, Karen
AU - Ang, Sonny A.
AU - Storti, Paola
AU - Viale, Andrea
AU - Giuliani, Nicola
AU - Ruisaard, Kathryn
AU - Ganan Gomez, Irene
AU - Bristow, Christopher A.
AU - Estecio, Marcos
AU - Weksberg, David C.
AU - Ho, Yan Wing
AU - Hu, Baoli
AU - Genovese, Giannicola
AU - Pettazzoni, Piergiorgio
AU - Multani, Asha S.
AU - Jiang, Shan
AU - Hua, Sujun
AU - Ryan, Michael C.
AU - Carugo, Alessandro
AU - Nezi, Luigi
AU - Wei, Yue
AU - Yang, Hui
AU - D'Anca, Marianna
AU - Zhang, Li
AU - Gaddis, Sarah
AU - Gong, Ting
AU - Horner, James W.
AU - Heffernan, Timothy P.
AU - Jones, Philip
AU - Cooper, Laurence J.N.
AU - Liang, Han
AU - Kantarjian, Hagop
AU - Wang, Y. Alan
AU - Chin, Lynda
AU - Bueso-Ramos, Carlos
AU - Garcia-Manero, Guillermo
AU - DePinho, Ronald A.
N1 - Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/5/11
Y1 - 2015/5/11
N2 - Myelodysplastic syndrome (MDS) risk correlates with advancing age, therapy-induced DNA damage, and/or shorter telomeres, but whether telomere erosion directly induces MDS is unknown. Here, we provide the genetic evidence that telomere dysfunction-induced DNA damage drives classical MDS phenotypes and alters common myeloid progenitor (CMP) differentiation by repressing the expression of mRNA splicing/processing genes, including SRSF2. RNA-seq analyses of telomere dysfunctional CMP identified aberrantly spliced transcripts linked to pathways relevant to MDS pathogenesis such as genome stability, DNA repair, chromatin remodeling, and histone modification, which are also enriched in mouse CMP haploinsufficient for SRSF2 and in CD34+ CMML patient cells harboring SRSF2 mutation. Together, our studies establish an intimate link across telomere biology, aberrant RNA splicing, and myeloid progenitor differentiation.
AB - Myelodysplastic syndrome (MDS) risk correlates with advancing age, therapy-induced DNA damage, and/or shorter telomeres, but whether telomere erosion directly induces MDS is unknown. Here, we provide the genetic evidence that telomere dysfunction-induced DNA damage drives classical MDS phenotypes and alters common myeloid progenitor (CMP) differentiation by repressing the expression of mRNA splicing/processing genes, including SRSF2. RNA-seq analyses of telomere dysfunctional CMP identified aberrantly spliced transcripts linked to pathways relevant to MDS pathogenesis such as genome stability, DNA repair, chromatin remodeling, and histone modification, which are also enriched in mouse CMP haploinsufficient for SRSF2 and in CD34+ CMML patient cells harboring SRSF2 mutation. Together, our studies establish an intimate link across telomere biology, aberrant RNA splicing, and myeloid progenitor differentiation.
UR - http://www.scopus.com/inward/record.url?scp=84929222950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929222950&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2015.04.007
DO - 10.1016/j.ccell.2015.04.007
M3 - Article
C2 - 25965571
AN - SCOPUS:84929222950
SN - 1535-6108
VL - 27
SP - 644
EP - 657
JO - Cancer cell
JF - Cancer cell
IS - 5
ER -